Biotech Acquisition Company filed its 10-K on Mar 08, 2022 for the period ending Dec 31, 2021. In this report its auditor, Marcum LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Biotech Acquisition Company
Equities
BIOT
KYG1125A1085
Investment Holding Companies
1st Jan change | Capi. | |
---|---|---|
+140.51% | 7.44B | |
+2.43% | 985M | |
+41.91% | 883M | |
+17.91% | 771M | |
+2.16% | 667M | |
+2.33% | 637M | |
-.--% | 600M | |
+8.33% | 526M | |
-.--% | 500M |